Central nervous system involvement in adult patients with diffuse large B-cell lymphoma: Influence of rituximab

被引：2

作者：

Cao, Bing ^{[1
,2
]}

Zhou, Xiaoyan ^{[2
,3
]}

Ji, Dongmei ^{[1
,2
]}

Cao, Junning ^{[1
,2
]}

Guo, Ye ^{[1
,2
]}

Zhang, Qunling ^{[1
,2
]}

Wu, Xianghua ^{[1
,2
]}

Li, Junmin ^{[4
]}

Wang, Jianmin ^{[5
]}

Chen, Fangyuan ^{[4
]}

Wang, Chun ^{[6
]}

Zou, Shanhua ^{[7
]}

Hong, Xiaonan ^{[1
,2
]}

机构：

[1] Fudan Univ, Dept Med Oncol, Shanghai Canc Ctr, Shanghai 200032, Peoples R China

[2] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai 200032, Peoples R China

[3] Fudan Univ, Dept Pathol, Shanghai Canc Ctr, Shanghai 200032, Peoples R China

[4] Shanghai Jiao Tong Univ, Dept Hematol, Ruijin Hosp, Shanghai 200030, Peoples R China

[5] Second Mil Med Univ, Dept Hematol, Changhai Hosp, Shanghai, Peoples R China

[6] Shanghai Jiao Tong Univ, Dept Hematol, Peoples Hosp 1, Shanghai 200030, Peoples R China

[7] Fudan Univ, Dept Hematol, Zhongshan Hosp, Shanghai 200032, Peoples R China

来源：

ONCOLOGY LETTERS | 2012年 / 4卷 / 03期

关键词：

central nervous system; diffuse large B-cell lymphoma; rituximab; ANTI-CD20 ANTIBODY RITUXIMAB; CHEMOTHERAPY PLUS RITUXIMAB; RANDOMIZED CONTROLLED-TRIAL; ELDERLY-PATIENTS; CHOP CHEMOTHERAPY; CNS LYMPHOMA; RISK-FACTORS; RICOVER-60; RELAPSE;

D O I：

10.3892/ol.2012.755

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

CHOP (cyclophosphamide, doxorubicin, vincristine and prednisone)-like chemotherapy, in combination with rituximab (R-CHOP-like), improves outcome in patients with diffuse large B-cell lymphoma (DLBCL). We aimed to investigate the impact of rituximab on central nervous system (CNS) disease in adult patients. We studied 315 patients (aged 18-60 years old) from six hospitals between July 2003 and May 2008. All patients received CHOP-like (n=165) or R-CHOP-like (n=150) regimen every 3 weeks. With a median follow-up of 3.69 years, 10 patients (3.17%) developed CNS disease. The cumulative risk of CNS occurrence was not significantly different between the two treatment groups (P=0.871). We conclude that the addition of rituximab did not reduce the risk of CNS disease in adult patients with DLBCL.

引用

页码：541 / 545

页数：5

共 50 条

[21] Gene expression profiles of central nervous system lymphoma predict poor survival in patients with diffuse large B-cell lymphoma [J].

Kagoya, Yuki ;

Nannya, Yasuhito ;

Nakamura, Fumihiko ;

Kurokawa, Mineo .

BRITISH JOURNAL OF HAEMATOLOGY, 2014, 166 (05) :794-797

[22] Prevention of central nervous system relapses in diffuse large B-cell lymphoma: which patients and how? [J].

Korfel, Agnieszka .

CURRENT OPINION IN ONCOLOGY, 2011, 23 (05) :436-440

[23] Central nervous system relapse in diffuse large B cell lymphoma: Risk factors [J].

Sancho, Juan-Manuel ;

Ribera, Josep-Maria .

MEDICINA CLINICA, 2016, 146 (02) :74-80

[24] Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab [J].

Tai, W. M. ;

Chung, J. ;

Tang, P. L. ;

Koo, Y. X. ;

Hou, X. ;

Tay, K. W. ;

Quek, R. ;

Tao, M. ;

Lim, S. T. .

ANNALS OF HEMATOLOGY, 2011, 90 (07) :809-818

[25] Influence of Rituximab on Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma and Role of Prophylaxis-A Systematic Review of Prospective Studies [J].

Ghose, Abhimanyu ;

Elias, Harold Kunal ;

Guha, Gunjan ;

Yellu, Mahender ;

Kundu, Ria ;

Latif, Tahir .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (08) :451-457

[26] Secondary central nervous system involvement in patients with diffuse large B-cell lymphoma treated with rituximab combined CHOP therapy - a supplementary analysis of JCOG0601 [J].

Shimada, Kazuyuki ;

Ohmachi, Ken ;

Machida, Ryunosuke ;

Ota, Shuichi ;

Itamura, Hidekazu ;

Tsujimura, Hideki ;

Takayama, Nobuyuki ;

Shimada, Takaki ;

Kurosawa, Mitsutoshi ;

Tabayashi, Takayuki ;

Shimoyama, Tatsu ;

Ohshima, Koichi ;

Miyazaki, Kana ;

Maruyama, Dai ;

Kinoshita, Tomohiro ;

Ando, Kiyoshi ;

Hotta, Tomomitsu ;

Tsukasaki, Kunihiro ;

Nagai, Hirokazu .

ANNALS OF HEMATOLOGY, 2024, 103 (06) :2021-2031

[27] Diffuse large B-cell lymphoma with involvement of the kidney: outcome and risk of central nervous system relapse [J].

Villa, Diego ;

Connors, Joseph M. ;

Sehn, Laurie H. ;

Gascoyne, Randy D. ;

Savage, Kerry J. .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (07) :1002-1007

[28] New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study [J].

Cai, Qing-Qing ;

Hu, Li-Yang ;

Geng, Qi-Rong ;

Chen, Jie ;

Lu, Zhen-Hai ;

Rao, Hui-Lan ;

Liu, Qing ;

Jiang, Wen-Qi ;

Huang, Hui-Qiang ;

Lin, Tong-Yu ;

Xia, Zhong-Jun .

CHINESE JOURNAL OF CANCER, 2016, 35 :87

[29] Central nervous system involvement in intravascular large B-cell lymphoma: A retrospective analysis of 109 patients [J].

Shimada, Kazuyuki ;

Murase, Takuhei ;

Matsue, Kosei ;

Okamoto, Masataka ;

Ichikawa, Naoaki ;

Tsukamoto, Norifumi ;

Niitsu, Nozomi ;

Miwa, Hiroshi ;

Asaoku, Hideki ;

Kosugi, Hiroshi ;

Kikuchi, Ako ;

Matsumoto, Morio ;

Saburi, Yoshio ;

Masaki, Yasufumi ;

Yamamoto, Kazuhito ;

Yamaguchi, Motoko ;

Nakamura, Shigeo ;

Naoe, Tomoki ;

Kinoshita, Tomohiro .

CANCER SCIENCE, 2010, 101 (06) :1480-1486

[30] Impact of rituximab on treatment outcomes of patients with diffuse large b-cell lymphoma: a population-based analysis [J].

Lee, Linda ;

Crump, Michael ;

Khor, Sara ;

Hoch, Jeffrey S. ;

Luo, Jin ;

Bremner, Karen ;

Krahn, Murray ;

Hodgson, David C. .

BRITISH JOURNAL OF HAEMATOLOGY, 2012, 158 (04) :481-488

← 1 2 3 4 5 →